Skip to main content

Table 2 Subgroup analyses after stratification for mean age, population, geographic area, and follow-up length

From: Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis

 

N

SPPB 0–3 vs. SPPB 10–12

N

SPPB 4–6 vs. SPPB 10–12

N

SPPB 7–9 vs. SPPB 10–12

15

OR (95% CI)

I2%

p

17

OR (95% CI)

I2%

p

17

OR (95% CI)

I2%

p

Mean age

   

0.37

   

0.19

   

0.24

 ≤75

7

3.54 (2.81–4.46)

0

 

8

2.40 (1.97–2.93)

0

 

8

1.65 (1.27–2.16)

59

 

 >75

8

3.12 (2.67–3.65)

0

 

9

2.04 (1.79–2.33)

0

 

9

1.38 (1.22–1.57)

0

 

Population

   

0.36

   

0.32

   

0.91

 General population

10

3.27 (2.86–3.75)

0

 

11

2.22 (1.98–2.49)

0

 

11

1.48 (1.32–1.65)

9

 

 Outpatients

2

2.53 (1.56–4.12)

0

 

3

1.45 (0.83–2.52)

14

 

3

1.48 (0.54–4.08)

80

 

 Hospitalized

3

4.93(2.18–11.14)

0

 

3

1.94 (0.85–4.41)

0

 

3

1.23 (0.53–2.85)

0

 

Geographic area

   

0.40

   

0.24

   

0.37

 Europe

11

3.44 (2.91–4.07)

0

 

11

2.02 (1.74–2.33)

3

 

11

1.42 (1.25–1.60)

0

 

 Asia

1

1.15(0.13–10.54)

–

 

1

3.94(1.34–11.56)

–

 

1

1.95 (0.82–4.63)

–

 

 North America

3

3.01(2.46–3.69)

0

 

5

2.34 (1.96–2.80)

0

 

5

1.79 (1.26–2.55)

73

 

Follow-up length

   

0.49

   

0.30

   

0.94

 ≤1 year

3

4.22 (1.97–9.02)

0

 

4

1.42 (0.65–3.10)

0

 

4

1.51 (0.50–4.59)

64

 

 >1 year

12

3.22 (2.83–3.69)

0

 

13

2.16 (1.94–2.41)

0

 

13

1.45 (1.32–1.60)

0

 
    

0.72

   

0.77

   

0.84

 ≤5 years

10

3.30 (2.82–3.86)

0

 

11

2.13 (1.86–2.43)

0

 

11

1.53 (1.23–1.91)

49

 

 >5 years

5

3.13 (2.48–3.96)

5

 

6

2.22 (1.73–2.85)

35

 

6

1.49 (1.27–1.75)

0

 
  1. SPPB Short Physical Performance Battery, N number of studies analyzed for subgroup